Catheter Connections receives another patent for IV disinfection technology

NewsGuard 100/100 Score

Catheter Connections, a start-up company co-founded by nurses seeking to reduce deadly hospital-acquired bloodstream infections, announced today the issuance of U.S. Patent Number 8,419,713, titled "Carrier Assembly With Caps for Medical Connectors." This is the seventh patent issued to the Company in a portfolio that broadly covers its DualCap® technology for disinfecting IV connectors — technology which helps protect hospital patients from deadly infections.

Catheter Connections is the only company to hold patents for protecting and disinfecting "male luer" connectors, which are used to connect IV tubing lines to IV catheters, a proven vector of microbes that can cause bloodstream infections. The patent covers the Company's new DualCap IV Pole Strips™. These new products are strips of disinfectant caps for IV connectors that hang from the IV pole, in the patient room and at the point of care, which provide quick and convenient access for the caregiver. The Company is the sole provider of disinfectant caps individually packaged in pouches, which keep the caps sterile, and IV Pole Strips of caps for convenient bedside access. "Today, success of a medical device is not only based on its proprietary technology, but also on its accessibility at the point of patient care and convenience of use. With the launch of our IV Pole Strips, Catheter Connections is now the only company with patented technology to protect male luers and needleless luer access valves. The Company now has the broadest product offering that allows each customer to select the product mix that best fits its individual needs. This is a significant advancement which positions the Company to lead the market with new, superior and patented products," said Vicki Farrar, CEO.

Source:

Catheter Connections, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech